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and Brian Custer for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II),
International Component
BACKGROUND: In Brazil little is known about adverse
reactions during donation and the donor characteristics
that may be associated with such events. Donors are
offered snacks and fluids before donating and are
required to consume a light meal after donation. For
these reasons the frequency of reactions may be differ-
ent than those observed in other countries.
STUDY DESIGN AND METHODS: A cross-sectional
study was conducted of eligible whole blood donors at
three large blood centers located in Brazil between July
2007 and December 2009. Vasovagal reactions (VVRs)
along with donor demographic and biometric data were
collected. Reactions were defined as any presyncopal
or syncopal event during the donation process. Multi-
variable logistic regression was performed to identify
predictors of VVRs.
RESULTS: Of 724,861 donor presentations, 16,129
(2.2%) VVRs were recorded. Rates varied substantially
between the three centers: 53, 290, and 381 per
10,000 donations in Recife, São Paulo, and Belo Hori-
zonte, respectively. Although the reaction rates varied,
the donor characteristics associated with VVRs were
similar (younger age [18-29 years], replacement donors,
first-time donors, low estimated blood volume [EBV]).
In multivariable analysis controlling for differences
between the donor populations in each city younger
age, first-time donor status, and lower EBV were the
factors most associated with reactions.
CONCLUSION: Factors associated with VVRs in other
locations are also evident in Brazil. The difference in
VVR rates between the three centers might be due to
different procedures for identifying and reporting the
reactions. Potential interventions to reduce the risk of
reactions in Brazil should be considered.
B
lood donation is recognized as an extremely
safe procedure;1,2 however, vasovagal (presyn-
copal and syncopal) reactions during or after
donation increase the potential for donor
injury. The prevalence of the vasovagal reactions (VVRs)
varies by country,1-8 and bymany other factors such as age,
sex, donation history (first-time vs. repeat), body mass
index (BMI), estimated blood volume (EBV) of donors,1,2
and type of donation (i.e., allogeneic or autologous whole
blood donation, plamaspheresis, plateletpheresis, and
multicomponent donations4 including double-red-blood-
cell collections9). Fortunately, the majority of adverse
events are minor in severity,8,10 but occasionally VVRs of
higher severity occur.11
In Brazil, a country with a population of about 190
million,12 the total annual allogeneic blood collection is
approximately 3 million units, or 21 blood donations per
ABBREVIATIONS: BMI = body mass index; EBV = estimated
blood volume; VVR(s) = vasovagal reaction(s); WBV = whole
blood viscosity.
From Blood Systems Research Institute, San Francisco,
California; the Fundação Pro-Sangue Hemocentro de São Paulo,
São Paulo, Brazil; Westat, Rockville, Maryland; the Fundação de
Hematologia e Hemoterapia de Pernambuco (HEMOPE), Recife,
Brazil; the Departamento de Medicina,Universidade de Per-
nambuco, Pernambuco, Brazil; the Mathematics and Statistics
Institute and the São Paulo Medical School, University of São
Paulo, São Paulo, Brazil; the Fundação Hemominas, Minas
Gerais, Brazil; and the Departments of Laboratory Medicine and
Epidemiology/Biostatistics, UCSF, San Francisco, California.
Address reprint requests to: Thelma T. Gonçalez, MD, PhD,
Blood Systems Research Institute, 270 Masonic Avenue, San
Francisco, CA 94118; e-mail: tgoncalez@bloodsystems.org.
Received for publication July 14, 2011; revision received
September 21, 2011, and accepted September 21, 2011.
doi: 10.1111/j.1537-2995.2011.03432.x
TRANSFUSION 2012;52:1070-1078.
1070 TRANSFUSION Volume 52, May 2012
1000 inhabitants.13 Specific procedures are defined for
donor recruitment, deferral criteria, laboratory tests,
proper handling, and related component preparation pro-
cedures.The regulations are similar to those in place in the
United States14 and Europe,15 and internationally accepted
procedures and guidelines are used as reference in the
development of Brazilian regulatory and practice guide-
lines.16 In Brazil little is known aboutVVRs associated with
blood donation, including the rates, severity, and charac-
teristics of blood donors who have adverse reactions and
variability of the VVRs between blood centers. We report
on the rates and risk factors for VVRs in Brazil.
MATERIALS AND METHODS
Overall study design
The NHLBI International REDS-II study in Brazil started
in 2007 and is composed of three major public blood
banks. Two of them are in the southeast (Fundação
Pro-Sangue, São Paulo and Fundação Hemominas, Belo
Horizonte, Minas Gerais),17 while the third is in the north-
east (Fundação Hemope, Recife, Pernambuco). This study
is a retrospective cross-sectional study of all allogeneic
donors who donated blood between July 2007 and
December 2009 at the three REDS-II international blood
sites in Brazil.
Measures
Data originate from standard procedures in place to
capture information over the course of blood donation. In
accord with Federal guidelines, it is mandatory to check
vital signs before donation.18 Each blood donormustmeet
acceptability criteria before being subjected to phle-
botomy. These criteria include age between 18 and 65
years, minimum weight 50 kg (110 lb), and being in good
general health. The acceptable vital signs at each center
are provided (Table 1) and are generally similar through-
out Brazil. A questionnaire concerning themedical history
is completed for every potential blood donor by a physi-
cian in Recife and BeloHorizonte and by a trained nurse in
São Paulo.
The Federal guidelines also recommend that no
blood should be collected from candidates who are fasting
and the blood center should offer a small snack before
donation. After the donation, it is obligatory to supply
adequate oral hydration and a light meal or snacks. There
are small differences in the donor intake procedures at the
blood centers. In São Paulo and Recife, the prospective
blood donor goes to the registration, then vital signs and
anemia testing, and if the blood donor is approved he or
she goes to the donation area. In Belo Horizonte after
acceptance for donation, donors go to the snack area and
then to the donation area. Restrictions are also in place
indicating that no blood should be collected from candi-
dates who ate a large meal, rich in fatty foods, or con-
sumed alcohol within 4 hours before donation. Of note,
there is no height restriction for blood donation in Brazil,
and weight is usually self-reported.
A trained technician performs the phlebotomy in a
separate room in the blood bank while the donor is in a
semisupine position. The total volume of blood to be col-
lected should not exceed 8 mL/kg for women and 9 mL/kg
for men. The allowed donation volume is 450  50 mL,
which may be increased by 30 mL to perform laboratory
tests required by law and technical internal guidelines.
Table 1 shows the criteria for blood donation at each
REDS-II Brazil blood center. After the blood collection, the
blood donor remains seated for about 10 minutes and if
she or he feels well, a light meal and refreshments are
served at the canteen under attention of a trained techni-
cian for 15 minutes or more.
Only allogeneic whole blood donationswere included
in this analysis. Whole blood donation represents 98% of
all of the donations in the REDS-II Brazil data set. Esti-
mated blood volume (EBV) was calculated based on the
formula of Nadler and colleagues19 based on sex, height,
andweight. Of note, height andweight are self-reported in
TABLE 1. Criteria for blood donation at each REDS-II Brazil blood center
Criterion Recife Belo Horizonte São Paulo
Age (years) 18  age  65 18  age  65 18  age  65
Weight 50 kg or 110 lb 50 kg or 110 lb 50 kg or 110 lb
Pulse 60  pulse  100 bpm 60  pulse  100 bpm 60  pulse  100 bpm
Blood pressure (BP) (mmHg)
Systolic 100  BP  160 100  BP  180 100  BP  180
Diastolic 60  BP  100 60  BP  90 60  BP  90
Hct or Hb
Male Hb: 13 g/dL Hb: 13 g/dL 39  Hct  54
39  Hct  55
Female Hb: 12.5 g/dL Hb: 12.5 g/dL 38  Hct  50
38  Hct  54
Collection volume (mL) 450 mL 450 mL† 450 mL*
* São Paulo: males  50 kg = 450 mL; females  50 to 57 kg = 400 mL; females  57 kg = 450 mL.
† Belo Horizonte: males  50 kg = 450 mL; females  50 to 55 kg = 410 mL; females > 55 kg = 450 mL.
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all three blood centers. VVRs are reported on nonstand-
ardized forms; however, all forms capture specific symp-
toms of the reaction, monitoring of vital signs, and
medical interventions received. Vasovagal adverse reac-
tions were classified into three categories of severity: mild
grade for presyncopal VVRs such as pallor, sweating,
anxiety; moderate grade for hypotension, vomiting, and
transient loss of consciousness; and severe grade for loss
of consciousness associated with other signs and symp-
toms such as recurrent vomiting, prolonged pulse and/or
blood pressure recovery times, incontinence, and convul-
sions, among other signs and symptoms. Only VVRs that
occurred during or immediately after blood donation,
while the blood donors still were at the blood center pre-
mises are included in this analysis. Needle-related injuries
were excluded.
Statistical analysis
Unadjusted rates of reaction were calculated as the pro-
portion of reactions out of all whole blood donation
attempts overall and according to blood center and also
donor demographic and biometric characteristics. Reac-
tion rates and rates by severity category are expressed per
10,000 donations. Multivariable logistic regression analy-
sis was performed to identify the predictors of VVRs asso-
ciated with whole blood donation. All reactions were
grouped into a single indicator variable for logistic regres-
sion analysis. Due to colinearity between EBV and BMI
and separately between systolic and diastolic blood pres-
sure, the logistic regression included only one of each pair.
The decision of what to include was based on clinical con-
siderations, since statistically the effects were indistin-
guishable. Results are reported as adjusted odds ratios
(AORs) with associated 95% confidence intervals (95%
CIs). The p values shown in Table 4 test common OR or
center-specific OR for each characteristic in the model.
Analyses were conducted using computer software (SAS/
STAT, Version 9.2, SAS Institute, Inc., Cary, NC; and Excel,
Version 2010, Microsoft, Inc., Redmond, WA).
RESULTS
A total of 724,861 allogeneic whole blood donations were
attempted from July 2007 to December 2009 at the three
centers, with 331,316 (45%) in São Paulo, 258,109 (36%) in
Recife, and 135,436 (18.5%) in Belo Horizonte; 16,129
blood donors (2.2%) experienced VVRs (Table 2). Nearly
95% of VVRs were classified as mild, while 4.6% were
moderate and 0.9% severe. Fifty-four percent of donors
with reactions were male and 46% were female. Overall,
the age group of 18 to 29 years old represented 42% of
blood donors yet these young donors experienced 64% of
VVRs.
Seventy percent of donors were male and 30% were
female. However, only 54% of donors with reactions
were male, while 46% were female. Therefore, females
weremore likely to experienceVVRswith 339 reactions per
10,000 presentations compared to 172 reactions per
10,000 for males (Table 2), yielding a crude OR of 2.0 (95%
CI, 1.9-2.1).
Replacement donors (who gave blood for their friends
or relatives) had slightly higher rates of VVRs compared to
community donors (233 and 217 per 10,000, respectively).
High VVR rates were evident in first-time donors (428 per
10,000), donors aged 18 to 20 years (464 per 10,000), and
donors with lower EBV (457 per 10,000) or underweight
BMI (483 per 10,000). High pulse (>90 bpm) and low pulse
(<65 bpm) were positively associated with the VVR (329
per 10,000 and 254 per 10,000 vs. 204 per 10,000 for those
with pulse 65-90 bpm). Reaction rates were higher for
donors with lower blood pressures (whether diastolic or
systolic).
Importantly, the rates of VVR varied among the
centers: Belo Horizonte had the highest rates of VVRs (381
per 10,000) followed by São Paulo (290 per 10,000) and
Recife (53 per 100,000; Table 3). Reaction rates according
to demographic characteristics at each center also dem-
onstrated notable differences (Table 3). For example, reac-
tion rates by race/ethnicity categories are highly variable.
In Belo Horizonte donors with self-reported Asian race
had reaction rates of 574 per 10,000 whereas the rate
observed in Asian donors in Recife was 9 per 10,000. The
rate in Belo Horizonte was the highest for any race/
ethnicity category, while it was the lowest for any category
in Recife.
Multivariable logistic regression analysis confirmed
that VVRs in Brazil are highly associated with specific
donor characteristics (Table 4). Independent predictors of
VVRs include younger age, with donors 18 to 20 and
donors 21 to 24 years of age having odds of reactions
approximately threefold higher than for donors aged 41 to
65 (AOR 3.08, 95% CI 2.89-3.28; and AOR 2.80, 95% CI
2.64-2.97, respectively). First-time blood donors also had
higher odds of reactions compared to repeat donors
(AOR 2.49, 95% CI 2.41-2.58). Lower EBVs were associated
with higher odds of reactions across the three blood
centers.When compared to donors with EBVs of 5000 mL
or more, donors with EBV of less than 3500 mL were 1.8 to
2.6 times more likely to have a VVR depending on the
center, and other categories of EBV were also associated
with the risk of reactions. Race/ethnicities other than
white had significantly lower odds of reactions. Analysis of
the odds of VVRs by center showed that donors in Recife
had a lower odds of donors having documented reactions
(AOR 0.21, 95% CI 0.20-0.22) compared to São Paulo, but
Belo Horizonte was not significantly different than
São Paulo. An unexpected finding was the association
between increasing hematocrit (Hct) level and the odds of
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VVRs in São Paulo and in BeloHorizonte
(AOR 0.69 [95% CI 0.63-0.75] in São
Paulo and AOR = 0.77 [95% CI 0.69-0.85]
in Belo Horizonte) for donors with Hct
values between 38 and 39 when com-
pared to donors with Hct levels of 46 or
higher. We could not evaluate this rela-
tionship in Recife because Hct and/or
hemoglobin (Hb) values were not avail-
able in the analysis data set.
DISCUSSION
The aims of this study were to assess
the frequency of and factors associated
with VVRs in allogeneic whole blood
donors in Brazil. The frequency of
donation-related adverse events has
not previously been reported in the
peer-reviewed literature for Brazil. This
is the largest and first multicenter study
to assess risk factors for donor adverse
reactions. Results of our analysis show
that 2.3% of all whole blood donations
were complicated by a documented
VVR, which is higher than rates reported
in the general donor population in
Italy,3-5 India,20,21 Greece,6 and Den-
mark,22 but similar to findings from the
United States.1,23-25
Our study shows that youngage, low
EBV, and first-time blood donor status
are the major factors associated with
increased reaction rates, consistent
with previous studies.2,5,10,20,23 Like other
authors24,26,27 we found a low incidence
of serious reactions and no evidence
of severe events such as myocardium
infarction or thrombophlebitis, which
represent truly rare adverse complica-
tions of blood donation. Many
studies1,2,9,23,25,28,29 have observed that
first-time donors were more likely to
experience VVRs. We confirmed that
replacement blood donors presented a
slightly higher likelihood of adverse
reaction, consistent with the finding
of others.5,6 Synergistic psychological
mechanisms might be driving these
findings. A first-time donation is associ-
ated with anxiety in inexperienced
donors relative to repeat donors who are
familiar with the donation process.30
Moreover, donations from replacement
donors may include an extra layer of
TABLE 2. Reaction rate by demographic characteristics*
Characteristic No reactions Reactions
Rate of reaction
(per 10,000 donations)
Reaction grade
Mild 15,239 (94.5) 210
Moderate 745 (4.6) 10
Severe 145 (0.9) 2
Overall 708,732 (100.0) 16,129 (100.0) 222
Sex
Female 212,812 (30.0) 7,466 (46.3) 339
Male 495,920 (70.0) 8,663 (53.7) 172
Age (years)
18-20 59,282 (8.4) 2,887 (17.9) 464
21-24 99,642 (14.1) 3,793 (23.5) 367
25-29 138,077 (19.5) 3,703 (23.0) 261
30-40 229,513 (32.4) 3,946 (24.5) 169
41-65 182,079 (25.7) 1,800 (11.1) 98
Missing 139 (0.0) 0 (0.0)
Donor type
Community 455,505 (64.3) 10,092 (62.6) 217
Replacement 253,227 (35.7) 6,037 (37.4) 233
Donation history
First-time 223,405 (31.5) 9,996 (62.0) 428
Repeat 485,327 (68.5) 6,133 (38.0) 125
Race/ethnicity
Black 74,054 (10.4) 1,142 (7.1) 152
Mixed 297,053 (41.9) 5,299 (32.8) 175
White 274,620 (38.7) 8,059 (50.0) 285
Asian 7,160 (1.0) 202 (1.2) 274
Indigenous 2,034 (0.3) 70 (0.4) 333
Missing 53,811 (7.6) 1,357 (8.4)
EBV (mL)
<3500 30,780 (4.3) 1,474 (9.1) 457
3500-3999 80,164 (11.3) 3,117 (19.3) 374
4000-4499 101,218 (14.3) 2,834 (17.6) 272
4500-4999 154,046 (21.7) 3,201 (19.8) 204
5000 231,606 (32.7) 3,543 (22.0) 150
Missing 110,918 (15.6) 1,960 (12.2)
BMI
Underweight 4,355 (0.6) 221 (1.4) 483
Normal 263,008 (37.1) 8,264 (51.2) 305
Overweight 233,043 (32.9) 4,299 (26.6) 181
Obese 77,962 (11.0) 1,140 (7.1) 144
Severely obese 19,446 (2.7) 245 (1.5) 125
Missing 110,918 (15.7) 1,960 (12.2)
Pulse (bpm)
<65 62,001 (8.8) 1,614 (10.0) 254
65-90 479,472 (67.6) 9,993 (62.0) 204
>90 66,552 (9.4) 2,262 (14.0) 329
Missing 100,707 (14.2) 2,260 (14.0)
Diastolic BP (mmHg)
<60 24,858 (3.5) 808 (5.0) 315
60-100 534,884 (75.5) 12,144 (75.3) 222
>100 56,190 (7.9) 921 (5.7) 161
Missing 92,800 (13.1) 2,256 (14.0)
Systolic BP (mmHg)
<100 781 (0.1) 41 (0.2) 499
100-160 546,536 (77.1) 12,526 (77.7) 224
>160 68,889 (9.7) 1,315 (8.2) 188
Missing 92,526 (13.1) 2,247 (13.9)
Blood center
Recife 256,752 (36.2) 1,357 (8.4) 53
Belo Horizonte 130,283 (18.4) 5,153 (32.0) 381
São Paulo 321,697 (45.4) 9,619 (59.6) 290
Hct (g/dL)†
38-39 55,638 (12.4) 1,989 (13.7) 345
40-41 77,003 (17.2) 2,706 (18.7) 340
42-43 86,854 (19.4) 2,691 (18.6) 301
44-45 88,444 (19.8) 2,681 (18.5) 294
46 138,969 (31.1) 4,424 (30.5) 309
* Data are reported as n (%).
† Quantitative Hct data are unknown for more than 95% of the records at Recife blood
center.
ADVERSE DONOR REACTIONS IN BRAZIL
Volume 52, May 2012 TRANSFUSION 1073
anxietydue todesire toprovideblood fora friendor relative
in need of transfusion,6 whereas community donors come
to donate blood to help anonymously individuals with no
specific emotional connection with the recipient other
than “helping society.”31
Unadjusted analyses indicated a
higher rate of VVRs among females,
as reported in other studies.1,9,20,26,29
However, after adjusting for other risk
factors, female sex was not a significant
predictor of VVRs in our multivariable
analysis. Of note, we used Nadler’s sex-
specific formulas to calculate EBV that
may have inherently controlled for any
potential sex effect. However, there are
also other factors related to differences
in the allowed collection volume
betweenmales and females that may be
relevant. Brazilian blood bank regula-
tions18 limit the donation amount to
450  50 mL, which may be increased
by 30 mL to perform laboratory tests.
Combining the minimum weight
requirement of 50 kg (110 lb) for blood
donation and blood volume require-
ment results in an allowed maximum
blood loss per donation of 430 mL for a
50-kg female and 480 mL for a 50-kg
male donor, representing 18 and 14%
smaller draw volumes, respectively,
than allowed in the United States.14 The
standards in Brazil are similar to the
450-mL standard volume collected in
Europe.15,32 Given these factors we
expected that we might find VVR rates
similar to those in Europe, but our study
shows that the Brazilian rate of VVRs is
higher when compared to reports from
Europe.3,5,32
Our study has demonstrated an
unexpected (and unreported) effect
related to increasing Hct and higher
likelihood of adverse reactions. One
hypothesis that might explain this
finding relates to whole blood viscosity
(WBV).33 It has been shown that Hct is
one of the principal determinants of
WBV. Hct has the greatest effect onWBV
during high-velocity blood flow; for
instance, a 10% increase in Hct typically
increases viscosity at high shear rates
(arterial flow) by about 20%.34 WBV is
also a key determinant of the overall
work load on the heart and perfusion of
tissues. In addition, there is also a rela-
tionship between WBV and blood pressure. If WBV
increases then total peripheral resistance will increase,
thereby reducing blood flow. Conversely, when WBV
decreases, blood flow and perfusion will increase.35 These
physiological considerations might explain the relation-
TABLE 3. Reaction rate by blood center and demographic
characteristics
Characteristic
Recife (per 10,000
donations)
Belo Horizonte
(per 10,000
donations)
São Paulo
(per 10,000
donations)
Reaction grade
Mild 48 355 277
Moderate 1 23 12
Severe 4 2 1
Overall 53 380 290
Sex
Female 100 550 348
Male 42 285 256
Age (years)
18-20 104 743 661
21-24 80 576 491
25-29 67 408 336
30-40 39 278 224
41-65 27 186 126
Donor type
Community 44 350 272
Replacement 61 402 387
Donation history
First-time 110 630 554
Repeat 29 222 167
Race/ethnicity
Black 34 235 174
Mixed 51 354 240
White 57 437 344
Asian 9 574 294
Indigenous 178 429 286
EBV (mL)
<3500 183 709 459
3500-3999 113 614 384
4000-4499 79 416 330
4500-4999 50 326 276
5000 34 242 213
BMI
Underweight 198 541 562
Normal 81 450 365
Overweight 43 321 237
Obese 38 293 199
Severely obese 34 253 169
Pulse (bpm)
<65 73 364 248
65-90 55 415 281
>90 57 478 356
Diastolic BP (mmHg)
<60 94 502 336
60-100 54 403 302
>100 34 261 196
Systolic BP (mmHg)
<100 0 640 574
100-160 56 410 304
>160 30 294 219
Hct (g/dL)*
38-39 458 290
40-41 428 304
42-43 371 273
44-45 327 282
46 337 299
* Quantitative Hct data are unknown for over 95% of the records at Recife blood center.
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ship between higher Hct and adverse reaction events.
High Hct may act to further restrict blood flow during
vasovagal events. Further studies to evaluate the relation-
ship between Hct and VVRs in blood donors are needed.
This study has several limitations. First, we lacked
records regarding the onset time of VVRs and had limited
access to some other data such as information on the
occurrence of delayed reactions and the lack of Hct
and/or Hb data for one of the centers. Consequently we
could not examine all types of VVRs or factors associated
with reactions that occurred after
leaving the blood center. Second, weight
and height were self-reported leading to
the possibility of under- and overesti-
mation of each value. Third, although
moderate and severe reactions are rela-
tively uncommon compared to mild
reactions, establishing a clear distinc-
tion between the reaction severities is
difficult since the classification is a sub-
jective decision by blood center staff.
Furthermore, adverse events are not
recorded on standardized reporting
forms across the three blood centers.
Different forms and different center
practices regarding the classification of
signs and symptoms of VVRs may have
been substantial contributors to differ-
ences in reaction rates across blood
centers. For these reasons we did not
conduct analyses that sought to deter-
mine if specific demographic character-
istics may be associated with different
reaction severities.
Evidence of remarkable differences
in VVR rates at different blood centers is
not unique to Brazil. Analyses con-
ducted in the United States have
reported similar large differences by
center.1,2,36,37 There are considerable
regional demographic and cultural dif-
ferences between the southeastern and
northeastern parts of Brazil.38,39 Demo-
graphics and blood center procedures
may contribute to the difference seen
between VVR rates observed at the
REDS-II Brazil centers. Additional
explanations include the possibility that
VVRs may not have been recorded in
Recife due to differences in standard
operating procedures. Developing con-
sistent reporting practices using
common definitions across the Brazil-
ian blood bank network would be the
first step to understand that the differ-
ences in adverse reactions by center are significant as
reported here.
Offering fluids and light snacks before starting the
phlebotomy has been proposed as a method to decrease
the development ofVVRs among blood donors.40,41 Yet, the
provision of snacks and fluids before donation as a means
of reducing VVRs does is not consistent with our findings,
since VVRs are higher in Belo Horizonte despite the fact
that the Belo Horizonte blood center requires that donors
have fluids and a light snack before donation whereas this
TABLE 4. OR from multivariable logistic regression analysis showing
predictors of reaction in blood donors in Brazil*
All Centers—OR (95% CI)
Characteristic Recife‡ Belo Horizonte São Paulo
Sex p < 0.0001 p < 0.0001 p < 0.0001
Female 1.36 (1.17, 1.60) 1.49 (1.36, 1.62) 0.86 (0.79, 0.92)
Male 1.0 1.0 1.0
EBV (mL) p < 0.0001 p < 0.0001 p < 0.0001
<3500 2.61 (1.98-3.44) 1.77 (1.48-1.98) 2.12 (1.92-2.35)
3500-3999 1.83 (1.45-2.31) 1.56 (1.38-1.76) 1.89 (1.74-2.06)
4000-4499 1.78 (1.48-2.13) 1.34 (1.20-1.50) 1.61 (1.50-1.74)
4500-4999 1.36 (1.16-1.61) 1.27 (1.15-1.41) 1.29 (1.21-1.36)
5000 1.0 1.0 1.0
Hct (g/dL) p = 0.0002 p < 0.0001
38-39 0.77 (0.69-0.85) 0.69 (0.63-0.75)
40-41 0.85 (0.77-0.94) 0.81 (0.75-0.87)
42-43 0.87 (0.79-0.96) 0.80 (0.75-0.86)
44-45 0.90 (0.82-0.98) 0.93 (0.87-0.98)
46 1.0 1.0
Blood center† p < 0.0001
Recife 0.21 (0.20-0.22)
Belo Horizonte 1.38 (1.32-1.45)
São Paulo 1.0
Age (years) p < 0.0001
18-20 3.08 (2.89-3.28)
21-24 2.80 (2.64-2.97)
25-29 2.27 (2.14-2.41)
30-40 1.70 (1.61-1.80)
41-65 1.0
Donor type p < 0.0001
Community 1.0
Replacement 1.09 (1.05-1.13)
Donation history p < 0.0001
First-time 2.49 (2.41-2.58)
Repeat 1.0
Race/ethnicity p < 0.0001
Black 0.51 (0.48-0.54)
Mixed 0.73 (0.70-0.76)
White 1.0
Asian 0.75 (0.65-0.87)
Indigenous 0.81 (0.64-1.03)
Pulse (bpm) p < 0.0001
<65 0.77 (0.72-0.83)
65-90 0.85 (0.81-0.89)
>90 1.0
Diastolic BP (mmHg) p < 0.0001
<60 1.11 (1.00-1.23)
60-100 1.17 (1.09-1.26)
>100 1.0
* p values for testing common ORs and for center-specific ORs (Sex, EBV, and Hct) of
each characteristic are shown in table.
† Average center difference.
‡ Quantitative Hct data are unknown for more than 99% of the records at Recife blood
center.
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is only a recommendationgiven todonors inSãoPauloand
Recife. This finding suggests that other variables such as
emotional or psychological factors in association with the
percentage of blood volume drawnmay play an important
role in the prevalence ofVVR. It has been already described
that donors who present adverse reactions tend to be
hypochondriac, depressed, and overly concerned with
their bodily functions and are more prone to feelings of
uselessness and pessimism.42,43 This psychological aspect
might explain why phlebotomist skills are related to lower
donor reaction rate, for instance, lower rateswereobserved
when more attention was given to the donors and more
talkative nurses had lower rates of blood donors reac-
tions.44 Syncope and presyncope are also related to blood
or injury phobia; that is, the fear can be triggered by seeing
blood, by sustaining an injury, or by receiving an injection
or someother invasivemedicalprocedure.45-49 In summary,
the interaction between psychosocial characteristics and
biophysical characteristics and the impact of these factors
mechanistically on vasovagal and other reactions has not
been completely elucidated.42,43
Our results show that the risk factors for VVRs among
the Brazilian blood donor population are similar to those
observed in other countries,2-4,6,7,32 even though blood
donor eligibility and donation procedures are not the
same. Overall, the Brazilian blood donor population is
younger than the blood donor population in the United
States50,51 and Europe52 and the highest rates of reaction
VVRs were found within younger age donors. Efforts to
reduce the risk of VVRs in donors in Brazil is important as
part of donor vigilance and also may be increasingly
important as blood centers in Brazil seek to convert
young, first-time donors into long-term repeat blood
donors.
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